Suppr超能文献

相似文献

1
Current Approaches to COVID-19: Therapy and Prevention.
Indian J Crit Care Med. 2020 Sep;24(9):838-846. doi: 10.5005/jp-journals-10071-23470.
2
Cytokine Storm in Novel Coronavirus Disease (COVID-19): Expert Management Considerations.
Indian J Crit Care Med. 2020 Jun;24(6):429-434. doi: 10.5005/jp-journals-10071-23415.
5
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
Cochrane Database Syst Rev. 2020 May 14;5(5):CD013600. doi: 10.1002/14651858.CD013600.
7
Insight in the Current Progress in the Largest Clinical Trials for Covid-19 Drug Management (As of January 2021).
Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2021 Apr 23;42(1):5-18. doi: 10.2478/prilozi-2021-0001.
8
Critical Care for COVID-19 Affected Patients: Updated Position Statement of the Indian Society of Critical Care Medicine.
Indian J Crit Care Med. 2020 Nov;24(Suppl 5):S225-S230. doi: 10.5005/jp-journals-10071-23621.
10
Effectiveness of Remdesivir, Lopinavir/Ritonavir, and Favipiravir for COVID-19 Treatment: A Systematic Review.
Int J Gen Med. 2021 Nov 23;14:8557-8571. doi: 10.2147/IJGM.S332458. eCollection 2021.

引用本文的文献

1
Spectrum of COVID-19 induced liver injury: A review report.
World J Hepatol. 2024 Apr 27;16(4):517-536. doi: 10.4254/wjh.v16.i4.517.
5
SARS-CoV-2 infection and diabetes: Pathophysiological mechanism of multi-system organ failure.
World J Virol. 2022 Sep 25;11(5):252-274. doi: 10.5501/wjv.v11.i5.252.
6
Efficacy of tocilizumab in the treatment of COVID-19: An umbrella review.
Rev Med Virol. 2022 Nov;32(6):e2388. doi: 10.1002/rmv.2388. Epub 2022 Aug 27.
7
Mechanisms of COVID-19 pathogenesis in diabetes.
Am J Physiol Heart Circ Physiol. 2022 Sep 1;323(3):H403-H420. doi: 10.1152/ajpheart.00204.2022. Epub 2022 Jul 1.
8
A cross-sectional study of COVID-19 outbreak in Indian population.
Ann Med Surg (Lond). 2022 Apr;76:103554. doi: 10.1016/j.amsu.2022.103554. Epub 2022 Apr 1.
10
COVID-19 Pandemic: An Opportunity for Universal Health Coverage.
Front Public Health. 2021 Jul 29;9:673542. doi: 10.3389/fpubh.2021.673542. eCollection 2021.

本文引用的文献

2
Cytokine Storm in Novel Coronavirus Disease (COVID-19): Expert Management Considerations.
Indian J Crit Care Med. 2020 Jun;24(6):429-434. doi: 10.5005/jp-journals-10071-23415.
5
Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply.
N Engl J Med. 2020 Sep 3;383(10):994. doi: 10.1056/NEJMc2022236. Epub 2020 Jul 10.
6
Early Short-Course Corticosteroids in Hospitalized Patients With COVID-19.
Clin Infect Dis. 2020 Nov 19;71(16):2114-2120. doi: 10.1093/cid/ciaa601.
7
Rationale for Prolonged Corticosteroid Treatment in the Acute Respiratory Distress Syndrome Caused by Coronavirus Disease 2019.
Crit Care Explor. 2020 Apr 29;2(4):e0111. doi: 10.1097/CCE.0000000000000111. eCollection 2020 Apr.
8
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验